Adaptimmune

Adaptimmune is an England-based biopharmaceutical company that researches and develops novel cell therapeutics for the treatment of cancer and infectious diseases.

Research Milton, United Kingdom Founded 2008 ~86 employees NASDAQ: ADAP

Work at Adaptimmune in HR or recruiting? Claim this page

Employees
86
0% in the 3 months to Sep 2026
Revenue / employee
$698K
Revenue ~$60M
Stock
ADAP
NASDAQ
12-month attrition
50.8%
Tech: 48.2%
H1B filings, FY2024
1
Sponsors visas

Headcount trend

Adaptimmune went from 263 employees in Oct 2024 to 86 in Sep 2026. Apr to Sep 2026: 0 people joined, 5 left.

Org structure

Headcount by department

Other49
Operations17
Engineering15
Finance2
Sales2
Marketing1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering1

Peer reviews

Worked with someone at Adaptimmune?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Adaptimmune FAQ

How many employees does Adaptimmune have?

Adaptimmune has about 86 employees, unchanged over the 3 months to Sep 2026.

Does Adaptimmune sponsor H1B visas?

Yes. Adaptimmune filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.

What is Adaptimmune's revenue per employee?

Adaptimmune makes about $698K in revenue per employee, based on $60M annual revenue and 86 employees.

Is Adaptimmune a public company?

Yes. Adaptimmune is publicly traded under the ticker ADAP on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.